RWE on High-Risk AML - Clinical Short Videos - European Medical Journal

RWE on High-Risk AML – Clinical Short Videos

Hematology

German RWE on High-Risk AML – Clinical Short Video

Watch this short promotional video from Jazz Pharmaceuticals on a summary of the German Real World Evidence (RWE) on high-risk* AML published by Rautenberg et al (2021)

Prescribing information and adverse event reporting details is available in the video
*High-risk AML defined as newly diagnosed, therapy-related AML (t-AML) or AML with myelodysplasia related changes (AML-MRC)

French RWE on High-Risk AML – Clinical Short Video

Watch this short promotional video from Jazz Pharmaceuticals on a summary of the French Real World Evidence (RWE) on high-risk* AML published by Chiche et al (2021)

Prescribing information and adverse event reporting details is available in the video

*High-risk AML defined as newly diagnosed, therapy-related AML (t-AML) or AML with myelodysplasia related changes (AML-MRC)

Italian RWE on High-Risk AML – Clinical Short Video

Watch this short promotional video from Jazz Pharmaceuticals on a summary of the Italian Real World Evidence (RWE) on high-risk* AML published by Guolo et al (2021)

Prescribing information and adverse event reporting details is available in the video

*High-risk AML defined as newly diagnosed, therapy-related AML (t-AML) or AML with myelodysplasia related changes (AML-MRC)

5-Year Follow-up Data in High-Risk AML – Clinical Short Video

Watch this short promotional video from Jazz Pharmaceuticals on a summary of the 5-year follow-up data in high-risk* AML published by Lancet et al (2021)

Prescribing information and adverse event reporting details is available in the video

*High-risk AML defined as newly diagnosed, therapy-related AML (t-AML) or AML with myelodysplasia related changes (AML-MRC)

Job code: INT-VYX-2100193

Date of prep: January 2022

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now